Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000447651Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in pain comparing Gabapentin with Pregabalin (2 arms). Primary endpoint: Quantitative analysis of gabapentin and pregabalin levels in breast milk and maternal plasma for pharmacokinetic modelling. Planned start Jan 2016; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000447651.